Correlation Between Anika Therapeutics and Sight Sciences

Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Sight Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Sight Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anika Therapeutics and Sight Sciences, you can compare the effects of market volatilities on Anika Therapeutics and Sight Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Sight Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Sight Sciences.

Diversification Opportunities for Anika Therapeutics and Sight Sciences

-0.1

Correlation Coefficient

Anika Therapeutics  Sight Sciences

Good diversification

The 3 months correlation between Anika and Sight is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Sight Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sight Sciences and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Sight Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sight Sciences has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Sight Sciences go up and down completely randomly.

Pair Corralation between Anika Therapeutics and Sight Sciences

Given the investment horizon of 90 days Anika Therapeutics is expected to generate 0.47 times more return on investment than Sight Sciences. However, Anika Therapeutics is 2.11 times less risky than Sight Sciences. It trades about 0.01 of its potential returns per unit of risk. Sight Sciences is currently generating about -0.23 per unit of risk. If you would invest  1,772  in Anika Therapeutics on November 28, 2024 and sell it today you would lose (1.00) from holding Anika Therapeutics or give up 0.06% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Anika Therapeutics  vs.  Sight Sciences

Anika Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward indicators, Anika Therapeutics is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Sight Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Anika Therapeutics and Sight Sciences

The main advantage of trading using opposite Anika Therapeutics and Sight Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Sight Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sight Sciences will offset losses from the drop in Sight Sciences' long position.

The idea behind Anika Therapeutics and Sight Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.